Analyst Price Targets — EHAB
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 24, 2026 1:12 am | — | UBS | $13.80 | $13.60 | TheFly | Enhabit downgraded to Neutral from Buy at UBS |
| February 23, 2026 6:26 pm | — | Jefferies | $13.80 | $13.60 | TheFly | Enhabit downgraded to Hold from Buy at Jefferies |
| February 23, 2026 3:25 pm | — | Leerink Partners | $13.80 | $13.60 | TheFly | Enhabit price target raised to $13.80 from $9.50 at Leerink |
| February 23, 2026 3:22 pm | — | Truist Financial | $13.80 | $13.60 | TheFly | Enhabit price target raised to $13.80 from $10.50 at Truist |
| January 22, 2026 11:47 am | Michael Wiederhorn | Oppenheimer | $14.00 | $10.74 | TheFly | Enhabit upgraded to Outperform from Perform at Oppenheimer |
| January 8, 2026 8:03 am | — | Wolfe Research | $12.00 | $9.51 | StreetInsider | UBS Upgrades Enhabit Home Health & Hospice (EHAB) to Buy |
| January 7, 2026 12:05 pm | — | Truist Financial | $10.50 | $9.44 | TheFly | Enhabit initiated with a Hold at Truist |
| December 16, 2025 1:39 pm | — | Jefferies | $12.00 | $9.73 | TheFly | Enhabit price target raised to $12 from $11 at Jefferies |
| December 9, 2024 9:41 am | Brian Tanquilut | Jefferies | $9.50 | $7.73 | StreetInsider | Jefferies Upgrades Enhabit Home Health & Hospice (EHAB) to Buy |
| May 14, 2024 6:14 am | Whit Mayo | Leerink Partners | $8.50 | $8.64 | TheFly | Enhabit upgraded to Market Perform from Underperform at Leerink |
No recent news available for EHAB.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for EHAB.
U.S. House Trading
No House trades found for EHAB.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.